← All trials
NCT00014742
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 10, 2001
- Primary completion
- —
- Completion date
- Apr 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 72
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- State University of New YorkLead sponsor
- State University of New YorkStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.